Manifold Biotechnologies, Inc. — Form D
Manifold Biotechnologies, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-13. The offering totals $5.4M, of which $5.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-08-13
- Form: D
- Accession: 0001820326-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.4M
- Amount sold: $5.4M
- Investors: 6
- Date of first sale: 2020-07-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-373197
Issuer
- Name: Manifold Biotechnologies, Inc.
- CIK: 0001820326
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 201 BROOKLINE AVENUE, BOSTON, MA, 02215
- Phone: (801) 244-4494
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jeff Huber | Director | San Francisco, CA |
| Steven Holtzman | Director | BOSTON, MA |
| Jory Bell | Director | Palo Alto, CA |
| Gleb Kuznetsov | Director | Boston, MA |
| Gleb Kuznetsov | Executive Officer | Boston, MA |
| Gleb Kuznetsov | Promoter | Boston, MA |
| Pierce Ogden | Director | Boston, MA |
| Pierce Ogden | Executive Officer | Boston, MA |
| Pierce Ogden | Promoter | Boston, MA |
| Steven J Kafka | Director | Boston, MA |
Other filings by this issuer (2)
More